Presentation Information

[1P-230]Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors in silico

○Kaori Asamitsu1, Takatsugu Hirokawa2, Takashi Okamoto1 (1. Nagoya City University, 2. University of Tsukuba)

Comment

To browse or post comments, you must log in.Log in